Home / Markets / News / Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

The Pharma benchmark has outperformed the overall market in recent trading sessions; sustenance above 200-DMA is likely to trigger further gains for it

Avdhut Bagkar |Business Standard | Mumbai
PremiumWeb Exclusive
Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

4 min read Last Updated : Oct 04 2022 | 11:05 PM IST
Follow Us

Listen to This Article

The Nifty Pharma index leaped over the 200-day moving average (DMA) on Monday for the first-time since this April. The inability to carry forward the buying momentum in that month had led the Pharma i

Topics :Sun PharmaNifty PharmaCiplaTorrent PharmaceuticalsGranules IndiaMarket trendsTrading strategiesStocks to buyPharma stocksstocks technical analysistechnical charts

First Published: Oct 04 2022 | 11:52 AM IST

Also Read

Tata Motors, Ashok Leyland, Eicher eye up to 17% gains, charts show

No need to worry till the Sensex holds 56,886 level, technical charts say

MNC stocks in focus: Charts show up to 17% upside in ABB, HUL, SKF India

Have the Indian stock markets rallied too fast, too soon?

Chart check: ITC could jump 40% on fresh breakouts, may hit Rs 400-mark

Blue Dart hits new high; rallies 14% in a week on 10% price hike decision

Analysts bullish on hospitals on expansion plans, recovery in non-Covid biz

Sensex jumps over 1,300 points: Top 4 factors behind Tuesday's bull run

Easy Trip Planners surges 8% on bonus issue, stock split plan

Review, GMP, valuations: Should you subscribe to Electronics Mart IPO?

Next Story